Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

OBJECTIVE: To assess whether adding or switching to sulfonylureas is associated with an increased risk of myocardial infarction, ischaemic stroke, cardiovascular death, all cause mortality, and severe hypoglycaemia, compared with remaining on metformin monotherapy in patients with type 2 diabetes. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Douros, Antonios, Dell’Aniello, Sophie, Yu, Oriana Hoi Yun, Filion, Kristian B, Azoulay, Laurent, Suissa, Samy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050517/
https://www.ncbi.nlm.nih.gov/pubmed/30021781
http://dx.doi.org/10.1136/bmj.k2693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050517/
https://www.ncbi.nlm.nih.gov/pubmed/30021781
http://dx.doi.org/10.1136/bmj.k2693

Ejemplares similares